ArticleRadiation oncology (London, England)2021

Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.